Next Generation Inactivated Polio Vaccine Manufacturing to Support Post Polio-Eradication Biosafety Goals | PLOS ONE
![Gavi, the Vaccine Alliance on Twitter: "Great news! Every country in the world – including all 73 Gavi-supported countries – have introduced inactivated polio vaccine (IPV). https://t.co/VaIFs5nV6L #EndPolio #IPV https://t.co/1JHXMucgcC" / Twitter Gavi, the Vaccine Alliance on Twitter: "Great news! Every country in the world – including all 73 Gavi-supported countries – have introduced inactivated polio vaccine (IPV). https://t.co/VaIFs5nV6L #EndPolio #IPV https://t.co/1JHXMucgcC" / Twitter](https://pbs.twimg.com/media/D6H3GgQXsAAeAT_.jpg)
Gavi, the Vaccine Alliance on Twitter: "Great news! Every country in the world – including all 73 Gavi-supported countries – have introduced inactivated polio vaccine (IPV). https://t.co/VaIFs5nV6L #EndPolio #IPV https://t.co/1JHXMucgcC" / Twitter
![Lower-dose aluminum hydroxide–adjuvanted polio vaccine noninferior to standard IPV | MDedge Infectious Disease Lower-dose aluminum hydroxide–adjuvanted polio vaccine noninferior to standard IPV | MDedge Infectious Disease](https://cdn.mdedge.com/files/s3fs-public/Polio_syringe_web.jpg)
Lower-dose aluminum hydroxide–adjuvanted polio vaccine noninferior to standard IPV | MDedge Infectious Disease
![Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority,](https://www.thelancet.com/cms/asset/76230417-f64b-44e0-88c0-fc723ea79dcf/gr1.gif)